Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (551-560 of 595) with videos related to

Pageof 60
Sort By:
Mutagenesis|September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Blood|May 6, 2006
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)Ayalew Tefferi, Giovanni Barosi, Ruben A Mesa, et al.
Blood|May 28, 2005
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersAmy V Jones, Sebastian Kreil, Katerina Zoi, et al.
Leukemia|February 5, 2015
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisM Arock, K Sotlar, C Akin, et al.
British Journal of Haematology|December 1, 2023
The management of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Bethan Psaila, Joanne Ewing, et al.
British Journal of Haematology|November 7, 2023
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Anna L Godfrey, Anna Green, et al.
Blood|September 9, 2006
Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disordersMarianna David, Nicholas C P Cross, Sonja Burgstaller, et al.
Leukemia|March 23, 2007
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaG Metzgeroth, C Walz, J Score, et al.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Pageof 60

Showing results (551-560 of 595) with videos related to

Sort By:
Pageof 60
Mutagenesis|September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Blood|May 6, 2006
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)Ayalew Tefferi, Giovanni Barosi, Ruben A Mesa, et al.
Blood|May 28, 2005
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersAmy V Jones, Sebastian Kreil, Katerina Zoi, et al.
Leukemia|February 5, 2015
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisM Arock, K Sotlar, C Akin, et al.
British Journal of Haematology|December 1, 2023
The management of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Bethan Psaila, Joanne Ewing, et al.
British Journal of Haematology|November 7, 2023
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology GuidelineDonal P McLornan, Anna L Godfrey, Anna Green, et al.
Blood|September 9, 2006
Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disordersMarianna David, Nicholas C P Cross, Sonja Burgstaller, et al.
Leukemia|March 23, 2007
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaG Metzgeroth, C Walz, J Score, et al.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Pageof 60